Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Inventory: 2024-2025

Historic Change in Inventory for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Sep 2025 value amounting to -$222,000.

  • Insight Molecular Diagnostics' Change in Inventory fell 195.69% to -$222,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $239,000, marking a year-over-year change of. This contributed to the annual value of $410,000 for FY2024, which is N/A change from last year.
  • Insight Molecular Diagnostics' Change in Inventory amounted to -$222,000 in Q3 2025, which was down 194.87% from $234,000 recorded in Q2 2025.
  • Insight Molecular Diagnostics' 5-year Change in Inventory high stood at $234,000 for Q2 2025, and its period low was -$222,000 during Q3 2025.
  • In the last 2 years, Insight Molecular Diagnostics' Change in Inventory had a median value of $178,000 in 2024 and averaged $94,200.
  • Data for Insight Molecular Diagnostics' Change in Inventory shows a maximum YoY plummeted of 195.69% (in 2025) over the last 5 years.
  • Over the past 2 years, Insight Molecular Diagnostics' Change in Inventory (Quarterly) stood at $178,000 in 2024, then slumped by 195.69% to -$222,000 in 2025.
  • Its Change in Inventory was -$222,000 in Q3 2025, compared to $234,000 in Q2 2025 and $49,000 in Q1 2025.